Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -15,205 | -7,513 | -2,534 | -16,259 |
| Depreciation Amortization | 528 | 355 | 166 | 332 |
| Accounts receivable | -289 | -1,539 | -1,671 | N/A |
| Accounts payable and accrued liabilities | -864 | 155 | -394 | N/A |
| Other Working Capital | -4,835 | -6,106 | -5,195 | 13,022 |
| Other Operating Activity | 3,441 | 2,082 | 2,355 | 1,490 |
| Operating Cash Flow | $-17,224 | $-12,566 | $-7,273 | $-1,415 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -776 | -650 | -264 | -1,113 |
| Investing Cash Flow | $-776 | $-650 | $-264 | $-1,113 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 1 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 57,876 |
| Financing Cash Flow | $1 | $N/A | $N/A | $57,876 |
| Exchange Rate Effect | -1,742 | -1,043 | 2,432 | 2,913 |
| Beginning Cash Position | 67,663 | 67,663 | 67,663 | 9,402 |
| End Cash Position | 47,922 | 53,404 | 62,558 | 67,663 |
| Net Cash Flow | $-19,741 | $-14,259 | $-5,105 | $58,261 |
| Free Cash Flow | ||||
| Operating Cash Flow | -17,224 | -12,566 | -7,273 | -1,415 |
| Capital Expenditure | -776 | -650 | -264 | N/A |
| Free Cash Flow | -18,000 | -13,216 | -7,537 | -1,415 |